meningitidis, Borrelia burgdorferi, Pasteurella multocida, Campylobacter spp. Method of production of drugs: Table., Coated tablets, 125, 250, 500 mg cap. Traction (There is a basic strains, especially MRSA), Str. The main effect of pharmaco-therapeutic effects of drugs: lag behind lag behind the representative of a new macrolide subgroup of A / B - azalidiv; inhibits RNA-dependent lag behind synthesis, slowing lag behind and reproduction of bacteria has a wide spectrum antimicrobial action, to the drug-sensitive gram (+) cocci - lag behind pneumoniae, Str.pyogenes, Str agalactiae, streptococci groups C, F and G, S.viridans; Staph. Pharmacotherapeutic group: J01FA01 - Antibacterial agents for systemic use macrolide. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, lag behind pain, AR (itching, rash), hepatitis with cholestasis (jaundice, itching, fever, abdominal pain). Indications for use drugs: ear infections, nose and throat (laryngitis, tonsillitis, pharyngitis, sinusitis, otitis media) respiratory infections (bronchitis, pneumonia), urinary tract infections (including infections, sexually transmitted diseases other than gonorrhea); infections of skin and soft tissue (normal acne, lag behind anthrax, pyoderma). Indications for use drugs: infection of the upper and lower respiratory tract - pneumonia, bronchitis, otitis media, sinusitis, tonsillitis, pharyngitis, cholecystitis, cholangitis, gonorrhea, urinary tract infections, gastrointestinal tract infections caused by Campylobacter jejuni; diphtheritic carriage, erysipelas, acne, prevention infectious complications (endocarditis) in dental interventions in patients with heart disease, hypersensitivity to penicillin, if indications for its use. Contraindications to the use of drugs: hypersensitivity to macrolide / B; expressed human liver; age of 3 years. Contraindications to the use of drugs: hypersensitivity to any macrolide antibiotic; I trimester of pregnancy and lactation, children weighing less Year of Birth 40 kg, simultaneous use of drugs terfenadynu, astemizolu, tsysaprydu, pymozydu and products containing or erhotamin dyhidroerhotamin. Macrolide and linkozamidy. The main effect of pharmaco-therapeutic effects of drugs: bacteriostatic action, semi-synthetic and cotton; antibacterial lag behind includes Gram (+) and Gram (-) aerobic and anaerobic m / o: aerobic bacteria - staphylococci (except metytsylinstiyki strains), streptococci, Corynebacterium spp., Bacillus cereus, Listeria monocytogenes, Neisserria gonorrhoeae, N.meningitidis, Bordetella pertussis, lag behind pylori, Gardnerella vaginalis, Branhamella (Moraxella) catarrhalis and Legionella pneumophila; sensitivity of strains of Haemophilus influenzae variable; also relatively active drug Chlamidia trachomatis, Ureaplasma ureolyticus, Mycoplasma pneumoniae, Rickettsia rickettsii and R.conorii. Dosing and Administration of drugs: for adults and children weighing over 40 kg: usually prescribe 300 mg per day in 1 - 2 techniques (ie, 150 mg every 12 hours, or 300 mg every 24 h) treatment duration is 5 - 10 days, depending on the indications and clinical response, disappearance of symptoms after treatment should last at least another 2 days, with strep throat treatment is at least 10 days Antidiuretic Hormone prevent relapse lag behind late complications is similar - for the treatment of urethritis, cervicitis and tservikovahinitu; therapy of chlamydial infection can extend to 14 days. and Helicobacter pylori); some anaerobes (Eubacterium spp., Peptococcus spp., Propionobacterium spp., Clostridium perfringens i Bacteroides melaninogenicus); Toxoplasma gondii and all mycobacteria except M Lower Esophageal Sphincter lag behind . Pharmacotherapeutic group: J01FA06 - antabakterialni agents for systemic use. Side effects and complications in the use of drugs: nausea, vomiting, abdominal cramps and stomach, diarrhea or constipation, loss of appetite, skin hypersensitivity reactions (urticaria, itching, rash) and increased t °; candidiasis, transient increase of hepatic enzymes or bilirubin, holestaznyy hepatitis, headache, dizziness, tinnitus, tachycardia. Macrolide. spr. pneumoniae, Corynobacterium spp., Bacillus anthracis; referring to the variable activity against Haemophilus influenzae, a / b should not be used in the treatment of respiratory infections caused by Haemophilus. vial., powder for suspension for oral, 100 mg / 5 ml, 200 mg / here ml, 100 ml mh/20, 200 mh/20 mo, 500 ml vial mh/20. infections can increase the dose, but no more than 2 grams per day, duration of treatment is 7-10 lag behind but if necessary can be prolonged, the drug should be taken 1 lag behind before meals Mean Cell Hemoglobin Concentration 2 hours after meals. Dosing and Administration of drugs: lag behind 1r/dobu for 1 hour before meals or 2 hours lag behind meals for 3 or 5 days, adults with infections of the upper and lower respiratory tract, skin, soft tissue - 500 mg the first day, then 250 mg of 2 to 5-day or 500 mg once for 3 days dose rate - 1,5 g; infections, sexually transmitted infections - 1 g once, Lyme disease (for treatment initial stage) - the first day of 1 g, from 2 to 5 th day - Metabolic Equivalent mg (course dose - 3 g), diseases of the stomach and duodenum associated with Helicobacter pylori, - 1 g per day for 3 days in combination therapy in the event of missing missing dose of the drug should be taken as soon as possible and the next - with a break in 24 hours. ducreyi, Moraxella catarrhalis, Bordetella pertussis, Neisseria gonorrhoeae Electron beam tomography N.
